EXTH-14. INHIBITION OF THE ANGIOTENSIN II TYPE 2 RECEPTOR AT2R IS A NOVEL THERAPEUTIC STRATEGY FOR GLIOBLASTOMA
Richard Perryman,Alexander Renziehausen,Hamidreza Shaye,Androniki D. Kostagianni,Antonis D. Tsiailanis,Thomas Thorne,Μaria V. Chatziathanasiadou,Gregory Sivolapenko,Mohamed A. El Mubarak,Gye Won Han,Barbara Zarzycka,Vsevolod Katritch,Guillaume Lebon,Cristiana Lo Nigro,Laura Lattanzio,Sophie V. Morse,James J. Choi,Kevin O’Neill,Zoe Kanaki,Apostolos Klinakis,Tim Crook,Vadim Cherezov,Andreas G. Tzakos,Nelofer Syed Neuro-Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper